Financials

  • Market Capitalization 6.19 M
  • Employee 4
  • Founded 2017
  • CEO David P Luci
  • Website www.acurxpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG01184DNJ4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4868
ADXN
Addex Therapeutics Ltd - American Depositary Shares
5.06 USD-9.64%-12.76%-12.76%-36.91%6.23 M USD
4869
PMCB
PharmaCyte Biotech, Inc. - Common Stock
0.58 USD-3.33%-3.33%-26.58%-43.14%6.23 M USD
4878
CURX
Curanex Pharmaceuticals Inc - Common Stock
0.21 USD+10.53%+5.00%-27.59%-94.47%5.96 M USD
4881
OABIW
OmniAb, Inc. - Warrant
0.0405 USD0.00%-33.61%-49.94%-80.24%5.87 M USD

Notizie